MONITORING OF GENE EXPRESSION IN TACROLIMUS-TREATED DE NOVO RENAL ALLOGRAFT RECIPIENTS FACILITATES INDIVIDUALIZED IMMUNOSUPPRESSION - RESULTS OF THE IMAGEN STUDY

被引：0
|
作者：
Sommerer, C. [1 ]
Millan, O. [2 ]
Glander, P. [3 ]
Brunet, M. [2 ]
Guirado Perich, L. [4 ]
Budde, K. [3 ]
Meuer, S. [5 ]
Zeier, M. [1 ]
Giese, T. [5 ]
机构：
[1] Univ Hosp Heidelberg, Nephrol, Heidelberg, Germany
[2] Hosp Clin Barcelona, Pharmacol & Toxicol Lab, Barcelona, Spain
[3] Charite, Nephrol, Berlin, Germany
[4] Fundacio Puigvert Barcelona, Renal Transplant Unit, Barcelona, Spain
[5] Univ Hosp Heidelberg, Immunol, Heidelberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2020年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
S24-03
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [41] Comparison of Renal Function in Orthotopic Liver Transplant Recipients Receiving Rabbit Antithymocyte Globulin Induction and De Novo Maintenance Immunosuppression with Sirolimus or Tacrolimus.
    Ally, Winston
    Duhart, Benjamin, Jr.
    Krauss, Amy
    Vanatta, Jason
    Mya, Maung
    Nezakatgoo, N.
    Eason, James
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 351 - 351
  • [42] Reduction in immunosuppression to prevent polyoma virus associated nephropathy (PVAN) in de novo renal transplant recipients:: A prospective study
    Almeras, Cyrielle
    Foulongne, Vincent
    Garrigue, Valerie
    Vetromile, Fernando
    Szwarc, Ilan
    Segondy, Michel
    Mourad, Georges
    TRANSPLANT INTERNATIONAL, 2007, 20 : 194 - 194
  • [43] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil (MMF) regimen in de novo renal allograft recipients: Renal function results from the Orion study
    Flechner, Stuart
    Glyda, Maciej
    Steinberg, Steven
    Harler, Mary Beth
    TRANSPLANT INTERNATIONAL, 2007, 20 : 25 - 25
  • [44] Conversion from cyclosporin (Neoral®) to tacrolimus (Prograf®) in renal allograft recipients with chronic graft nephropathy:: results of an observational study
    Morris-Stiff, GJ
    Baboolal, K
    Dunstan, F
    Jurewicz, WA
    TRANSPLANT INTERNATIONAL, 1999, 12 (04) : 288 - 292
  • [45] Cyclosporine C2 levels in de novo renal allograft recipients:: A German Multicenter Prospective Observational Study
    Arns, W
    Zantvoort, F
    Abendroth, D
    Seiter, H
    Scheuermann, EH
    Albert, U
    Stahl, R
    Fornara, P
    Fricke, L
    Neumayer, HH
    Nagel, E
    Michel, U
    Ulbricht, B
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (03) : 1612 - 1615
  • [46] Single-center study utilizing C2 level as monitoring tool in de novo renal transplant recipients treated with Neoral
    Keshavamurthy, M
    Al Ahmadi, I
    Raza, SM
    Baynton, R
    Al Meshari, K
    Al Shaibani, K
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3112 - 3114
  • [47] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (Tac) and mycophenolate mofetil (MMF) regimen in de novo renal allograft recipients: Renal function results from the ORION study.
    Flechner, Stuart
    Glyda, Maciej
    Steinberg, Steven
    Harler, M. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 440 - 440
  • [48] Preservation of Renal Function with Everolimus and Very Low Tacrolimus Exposure in De Novo Renal Transplant Recipients (RTxR) at 12 Months: The ASSET Study
    Pascual, J.
    Hene, R.
    Langer, R.
    Christiaans, M.
    Ciechanowski, K.
    Vilatoba, M.
    Dominguez, J.
    Wyzgal, J.
    Guerkan, A.
    Burgos, D.
    Vitko, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 502 - 502
  • [49] Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in De Novo renal transplant recipients?: A prospective study
    Almeras, Cyrielle
    Foulongne, Vincent
    Garrigue, Valerie
    Szwarc, Ilan
    Vetromile, Fernando
    Segondy, Michel
    Mourad, Georges
    TRANSPLANTATION, 2008, 85 (08) : 1099 - 1104
  • [50] Renal function with enteric-coated mycophenolate sodium in combination with reduced and standard tacrolimus levels: Results of a 6-month comparative study in de novo renal transplant recipients
    Hart, Marquis
    Chan, Laurence
    Andres, Amado
    Bloom, Roy
    Bunnapradist, Suphamai
    Kaplan, Bruce
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 583 - 583
12345